All In Biotech

NDA 017641 · Otsuka Icu Medcl

Lactated Ringer'S In Plastic Container

Calcium Chloride, Potassium Chloride, Sodium Chloride, Sodium Lactate · Injection

Last checked: Nov 19, 2026Latest source record: Jun 14, 2016 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1976

Jan 26, 1976

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

969

850 serious, 111 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Nov 2, 2025.

INDICATIONS AND USAGE These solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with or without minimal carbohydrate calories, as required by the clinical condition of the patient.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jan 26, 1976 Original approval · Type 5 - New Formulation or New Manufacturer
1 products under this application
  • LACTATED RINGER'S IN PLASTIC CONTAINER · CALCIUM CHLORIDE 20MG/100ML; POTASSIUM CHLORIDE 30MG/100ML; SODIUM CHLORIDE 600MG/100ML; SODIUM LACTATE 310MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • acute kidney injury63
  • dyspnoea62
  • tachycardia53
  • blindness50
  • hypotension47
  • pruritus43
  • pain38
  • chills33
  • rash33
  • vomiting33
  • cardiac arrest32
  • cough30

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200427
2005109
200641
200731
200852
200948
201045
201167
201260
201338
201467
2015174
2016120
201786
20264

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: Otsuka

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.